D. Turner

发表

Understanding the role of ETS-mediated gene regulation in complex biological processes.

David P Turner, V. Findlay, A. Larue, 2013, Advances in cancer research.

Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity.

David P Turner, D. Turner, 2015, Cancer research.

Defining ETS transcription regulatory networks and their contribution to breast cancer progression

David P Turner, V. Findlay, D. Turner, 2007, Journal of cellular biochemistry.

MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.

David P Turner, V. Findlay, D. Turner, 2008, Cancer research.

Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.

David P Turner, V. Findlay, A. Larue, 2011, Genes & cancer.

Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor Progression*

David P Turner, J. Richards, D. Turner, 2010, The Journal of Biological Chemistry.

BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivors.

Lourdes M. Nogueira, A. Alberg, V. Findlay, 2020, Advances in cancer research.

AGE Metabolites: A Biomarker Linked to Cancer Disparity?

Lourdes M. Nogueira, V. Findlay, D. Turner, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Dietary Advanced Glycation End-Products and Mortality after Breast Cancer in the Women's Health Initiative

David P Turner, Hailey R Banack, N. Saquib, 2021, Cancer Epidemiology, Biomarkers & Prevention.

The Role of Advanced Glycation End-Products in Cancer Disparity.

David P Turner, D. Turner, 2017, Advances in cancer research.

The role of bacterial ATP-binding cassette (ABC) transporters in pathogenesis and virulence: Therapeutic and vaccine potential.

David P Turner, D. Turner, Armaan A. Akhtar, 2022, Microbial pathogenesis.

Increased Preoperative Plasma Level of Microbial 16S rDNA Translocation Is Associated With Relapse After Prostatectomy in Prostate Cancer Patients

David P Turner, B. Zhu, D. Turner, 2020, Frontiers in Oncology.

Slug expression enhances tumor formation in a noninvasive rectal cancer model.

V. Findlay, D. Turner, D. Watson, 2011, The Journal of surgical research.

Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals

D. Turner, T. Ou, M. Lilly, 2022, Journal of immunology research.

Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts

David P Turner, Lourdes M. Nogueira, K. Helke, 2022, Translational oncology.

CHAPTER TWO: Disparities in Obesity, Physical Activity Rates, and Breast Cancer Survival

Kimberly R. Cannady, David P Turner, D. Turner, 2017, Advances in cancer research.

ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype.

V. Findlay, D. Turner, A. Liu, 2012, Carcinogenesis.

The Role of ETS Transcriptional Regulation in Hormone Sensitive and Refractory Prostate Cancer

David P Turner, D. Turner, 2010 .

ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression

V. Findlay, D. Turner, P. Watson, 2010 .

ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer

D. Turner, D. Watson, 2008, Expert review of anticancer therapy.

Hematopoietic Stem Cell–Derived Cancer–Associated Fibroblasts Are Novel Contributors to the Pro-Tumorigenic Microenvironment

Jeffrey A Jones, V. Findlay, A. Larue, 2015, Neoplasia.

Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression

David P Turner, V. Findlay, A. Larue, 2011, The Prostate.

Abstract B13: Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment

Jeffrey A Jones, David P Turner, V. Findlay, 2015 .

Hematopoietic Stem Cell-Derived Cancer-Associated Fibroblasts Are Novel Contributors to the

Jeffrey A Jones, David P Turner, South S. Carolina, 2015 .

MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer

Lourdes M. Nogueira, V. Findlay, A. Larue, 2013, Breast Cancer Research.

The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells)

David P Turner, D. Turner, J. Purves, 2015, International Urology and Nephrology.

Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO)

David P Turner, Jiajia Zhang, D. Turner, 2020, Cancer Prevention Research.

PDEF is a negative regulator of colon cancer cell growth and migration

David P Turner, V. Sementchenko, D. Turner, 2009, Journal of cellular biochemistry.

Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.

David P Turner, P. Fisher, D. Turner, 2007, Cancer research.

MicroRNA 204 mediated negative regulation of the IGF2R promotes breast cancer progression and is a potential mechanism driving breast cancer disparity

David P Turner, Lourdes M. Nogueira, K. Helke, 2013 .

Pubertal mammary development as a "susceptibility window" for breast cancer disparity.

David P Turner, V. Findlay, D. Turner, 2020, Advances in cancer research.

Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health‐AARP Diet and Health Study

David P Turner, G. Colditz, Seho Park, 2020, Cancer.

Dietary advanced glycation end products (AGEs) and breast cancer mortality in the women’s health initiative (WHI).

N. Saquib, L. Snetselaar, M. Neuhouser, 2020 .

Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.

V. Findlay, D. Turner, D. Watson, 2008, Molecular biology of the cell.

Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention

David P Turner, Lourdes M. Nogueira, S. Ambs, 2018, Breast Cancer Research and Treatment.

Breast Cancer Potential through the Inhibition of Migration and Invasion in Prostate-Derived ETS Factor Is a Mediator of Metastatic

David P Turner, P. Fisher, D. Turner, 2007 .